INGN  valuation analysis

Basics
Name: Inogen, Inc
Description: Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. (more)
Industry: Medical Devices
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2021
Market cap: $1.49B (1147th)
Sales(TTM): $306.93M (1305th)
Earnings(TTM): -$4.97M (1140th)

Value
FFER: 1.14 (why)
Actual price: $66.36
FFEThis is Inogen, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $58.22
Quantile: INGN is priced correctly given its fundamentals.
Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Inogen, Inc's earnings decreased from $14.06M to -$4.97M in the last year.
  • Inogen, Inc's operating income decreased from $12.75M to -$11.98M in the last year.
Earnings / MarketCap
Inogen, Inc
"Medical Devices" industry
Sales / MarketCap
Inogen, Inc
"Medical Devices" industry
Book / MarketCap
Inogen, Inc
"Medical Devices" industry
Equity / Assets
Inogen, Inc
"Medical Devices" industry